Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.57 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 12/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23953177 | 0.83 | PTGS2 (0.54) | CYP11B1CYP11B2PTGS2CA12CA1 | |
| SCHEMBL28022298 | 0.79 | PTGS2 (0.59) | PTGS2 | |
| SCHEMBL4941264 | 0.78 | SLC6A9 (0.52) | CYP11B1CYP11B2PTGS2CA12CA1 | |
| SCHEMBL4190362 | 0.78 | PTGS2 (0.72) | CYP11B1CYP11B2PTGS2CA12CA1 | |
| SCHEMBL31463157 | 0.77 | MMP3 (0.47) | CYP11B2CA12CA1CA2CA9 | |
| SCHEMBL803901 | 0.76 | PTGS2 (0.68) | CYP11B1CYP11B2PTGS2CA12CA1 | |
| SCHEMBL2893973 | 0.74 | EPAS1 (0.51) | CYP11B1CYP11B2PTGS2 | |
| SCHEMBL17714136 | 0.74 | CYP11B1 (1.00) | CYP11B1CYP11B2 | |
| SCHEMBL16014030 | 0.73 | PTGS2 (0.55) | PTGS2 | |
| SCHEMBL17630112 | 0.73 | VCAM1 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020035560-A1 | 1-METHYL-4-[(4-PHENYLPHENYL)SULFONYLMETHYL]CYCLOHEXYANOL AND 1-METHYL-4-[[4-(2-PYRIDYL)PHENYL]SULFONYLMETHYL]CYCLOHEXANOL COMPOUNDS AND THEIR THERAPEUTIC USE | Modern Biosciences Limited (GB) | 2020-02-20 | — | — | WO | disclosed |